The levels of serum soluble CD86 are correlated with the expression of CD86 variant 3 gene and are prognostic indicators in patients with myeloma.

Humans B7-2 Antigen / blood Disease Progression Multiple Myeloma / diagnosis Prognosis

Journal

Experimental hematology
ISSN: 1873-2399
Titre abrégé: Exp Hematol
Pays: Netherlands
ID NLM: 0402313

Informations de publication

Date de publication:
05 2023
Historique:
received: 10 08 2022
revised: 10 11 2022
accepted: 29 01 2023
medline: 28 4 2023
pubmed: 17 2 2023
entrez: 16 2 2023
Statut: ppublish

Résumé

We previously showed that cell-surface CD86 expressed on multiple myeloma (MM) cells contributed to not only tumor growth but also antitumor cytotoxic T-lymphocyte responses mediated by induction of IL-10-producing CD4

Identifiants

DOI: 10.1016/j.exphem.2023.01.006 PMID: 36796620
pubmed: 36796620
pii: S0301-472X(23)00029-2
doi: 10.1016/j.exphem.2023.01.006
pii:
doi:

Substances chimiques

B7-2 Antigen 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

38-47.e2

Informations de copyright

Copyright © 2023 ISEH -- Society for Hematology and Stem Cells. Published by Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Conflicts of Interest Disclosure The authors do not have any conflicts of interest to declare in relation to this work.

Auteurs

Ryosuke Kinoshita (R)

Department of Hematology, Nippon Medical School, Tokyo, Japan.

Mariko Ishibashi (M)

Department of Microbiology and Immunology, Nippon Medical School, Tokyo, Japan.

Hiroshi Handa (H)

Department of Hematology, Gunma University, Gunma, Japan.

Makoto Sasaki (M)

Department of Hematology, Juntendo University Graduate School of Medicine, Tokyo, Japan.

Yoichi Imai (Y)

Department of Hematology and Oncology, Dokkyo Medical University, Tochigi, Japan.

Norina Tanaka (N)

Department of Hematology, Tokyo Women's Medical University, Tokyo, Japan.

Shigeki Ito (S)

Department of Hematology/Oncology, Iwate Medical University School of Medicine, Iwate, Japan.

Mika Sunakawa-Kii (M)

Department of Hematology, Nippon Medical School, Tokyo, Japan.

Yuta Kaito (Y)

Department of Hematology, Nippon Medical School, Tokyo, Japan.

Toshio Asayama (T)

Department of Hematology, Nippon Medical School, Tokyo, Japan.

Norio Komatsu (N)

Department of Hematology, Juntendo University Graduate School of Medicine, Tokyo, Japan.

Junji Tanaka (J)

Department of Hematology, Tokyo Women's Medical University, Tokyo, Japan.

Takeshi Odajima (T)

Faculty of Health Science, Daito Bunka University School of Sports and Health Science, Saitama, Japan.

Hiroki Sugimori (H)

Department of Preventive Medicine, Daito Bunka University Graduate School of Sports and Health Science, Saitama, Japan.

Hiroki Yamaguchi (H)

Department of Hematology, Nippon Medical School, Tokyo, Japan.

Koiti Inokuchi (K)

Department of Hematology, Nippon Medical School, Tokyo, Japan.

Hideto Tamura (H)

Department of Hematology, Nippon Medical School, Tokyo, Japan; Division of Diabetes, Endocrinology and Hematology, Department of Internal Medicine, Dokkyo Medical University Saitama Medical Center, Saitama, Japan. Electronic address: tam@nms.ac.jp.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › The levels of serum soluble CD86 are...
questionsmedicales.fr › Facteurs biologiques › Protéines et peptides de signalisation intercellulaire › Antigènes B7 › Antigène CD86 › The levels of serum soluble CD86 are...
questionsmedicales.fr › États, signes et symptômes pathologiques › Processus pathologiques › Caractéristiques de la maladie › Évolution de la maladie › The levels of serum soluble CD86 are...
questionsmedicales.fr › Maladies du système immunitaire › Syndromes immunoprolifératifs › Paraprotéinémies › Myélome multiple › The levels of serum soluble CD86 are...
questionsmedicales.fr › Diagnostic › Pronostic › The levels of serum soluble CD86 are...